Clinical Trial Update: A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1) [NA]

View source ↗

Summary

An ongoing study to evaluate the feasibility of using pupillometry as a physiologic biomarker to assess pain and other sensory problems in people with Neurofibr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neurofibromatosis Type 1 | NA | Status: RECRUITING